Business Context and Reporting Period
This Form 8-K filing by Cohen & Steers, Inc. (CNS) was submitted on May 27, 2021, reporting events occurring on May 26, 2021. The filing addresses Item 5.02 regarding the departure, election, or appointment of certain officers.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and executive leadership changes.
Material Changes
The primary material change involves the resumption of duties by the Chief Executive Officer:
- Robert H. Steers: Previously on medical leave since February 22, 2021, Mr. Steers was reappointed as the Company's "principal executive officer" effective June 1, 2021. He will resume all duties as Chief Executive Officer on that date.
- Joseph M. Harvey: Mr. Harvey, who served as Acting Chief Executive Officer and "principal executive officer" during Mr. Steers' absence, will cease holding these titles effective June 1, 2021. He will continue in his roles as President and Board member.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on market conditions, or discussion of risks and contingencies. The document is strictly an announcement of executive role transitions.
Investor Verification Checklist
- Confirm the effective date of Robert H. Steers' return to full CEO duties (June 1, 2021).
- Verify that Joseph M. Harvey retains his position as President and Board member post-transition.
- Review prior filings (e.g., February 2021) for details on the initial medical leave announcement.